STE5 Antibody

What is STE5 and why are antibodies against it important in research?

STE5 is a scaffold protein that plays a critical role in the mitogen-activated protein kinase (MAPK) signaling pathway, particularly in yeast. It functions by facilitating the assembly of protein complexes involved in signal transduction. Research has demonstrated that STE5 undergoes dimerization during signal transduction, which appears essential for its function . STE5 antibodies are important research tools because they allow scientists to:

• Detect and quantify STE5 protein expression

• Verify protein interactions through co-immunoprecipitation experiments

• Validate genetic studies with protein-level confirmation

• Investigate signal transduction mechanisms in various experimental conditions

The ability to specifically detect STE5 using antibodies has been instrumental in elucidating its role in MAPK signaling pathways, particularly in model organisms like yeast where these pathways were first characterized in detail .

What are the common applications for STE5 antibodies in experimental settings?

STE5 antibodies are utilized in multiple experimental approaches for studying protein function and signal transduction:

• Western Blotting: For detecting STE5 expression levels and post-translational modifications. Typically performed with dilutions of 1:1000 to 1:10000, similar to other signaling protein antibodies .

• Immunoprecipitation: Critical for studying STE5 protein interactions and complex formation. This technique has been essential for demonstrating STE5 dimerization, as shown in studies where differently tagged forms of STE5 were co-expressed and co-immunoprecipitated .

• Protein Expression Verification: For confirming expression of wild-type and mutant STE5 constructs in genetic studies. For example, affinity-purified anti-STE5 antibodies directed at residues 336-468 of STE5 have been used to verify expression of deletion mutants in the ste5Δ background .

• Signal Transduction Studies: For investigating how STE5 participates in MAPK pathway activation in response to various stimuli.

When designing experiments using STE5 antibodies, researchers should consider protein expression levels, sample preparation methods, and potential cross-reactivity with related proteins.

How should STE5 antibodies be stored and handled to maintain optimal activity?

Proper storage and handling of STE5 antibodies are critical for maintaining their specificity and reactivity. Based on standard practices for research antibodies:

• Storage Temperature: Store antibodies at -20°C for long-term storage in small aliquots to avoid repeated freeze-thaw cycles. Some antibodies may require storage at -80°C; always follow manufacturer specifications.

• Working Dilutions: Prepare working dilutions immediately before use. For western blotting applications, dilutions typically range from 1:1000 to 1:10000 depending on the specific antibody and application .

• Buffer Compatibility: Ensure compatibility between the antibody and the buffer system used in your experiments. Some STE5 dimerization studies have shown sensitivity to buffer conditions, particularly those containing chelating agents like EGTA or 1,10-phenanthroline, which can disrupt protein-protein interactions .

• Avoid Contamination: Use sterile technique when handling antibody solutions to prevent microbial contamination.

• Blocking Conditions: For immunoblotting, optimal blocking conditions often include 3% milk in TBST solution for 1 hour at room temperature, similar to protocols used for other signaling pathway antibodies .

Following these guidelines will help ensure consistent and reliable results when using STE5 antibodies in research applications.

What methodological approaches are most effective for using STE5 antibodies in dimerization studies?

STE5 dimerization is a critical aspect of its function in signal transduction. Three complementary methodological approaches have proven particularly effective for investigating this phenomenon:

• Co-immunoprecipitation with Differently Tagged STE5 Variants: This approach has successfully demonstrated STE5-STE5 interactions by co-expressing two differentially tagged forms of STE5 (e.g., Myc-tagged STE5 and GST-STE5 fusion protein) and immunoprecipitating with antibodies against one tag. Western blotting with antibodies against the second tag can then detect co-immunoprecipitated protein. This method revealed that STE5 dimers can be disrupted by chelating agents like EGTA or 1,10-phenanthroline, suggesting involvement of the Lim-like zinc finger domain in dimerization .

• Two-Hybrid System Analysis: The yeast two-hybrid system provides a sensitive genetic method for detecting protein-protein interactions. This approach has confirmed STE5-STE5 interactions and helped map domains involved in dimerization .

• Genetic Complementation Assays: Intragenic complementation between pairs of non-functional STE5 mutants has provided physiologically relevant evidence for STE5 dimerization during signal transduction. This approach has the advantage of revealing interactions under normal cellular conditions during mating reactions .

When implementing these approaches, researchers should consider:

• The sensitivity of STE5 dimerization to buffer conditions

• The potentially transient nature of these interactions

• The importance of confirming results with multiple independent methods

These methodological considerations have been crucial for establishing the biological significance of STE5 dimerization in signal transduction pathways.

How can I optimize immunoprecipitation protocols when using STE5 antibodies?

Optimizing immunoprecipitation (IP) protocols for STE5 antibodies requires careful attention to several critical factors:

• Antibody Selection and Concentration: For direct immunoprecipitation of STE5, affinity-purified antibodies directed at specific regions (such as residues 336-468) have been successfully used . Alternatively, epitope-tagged versions of STE5 can be immunoprecipitated using commercially available tag-specific antibodies (e.g., anti-Myc at 1:10000 dilution for Myc-tagged STE5) .

• Lysis Buffer Composition: The choice of lysis buffer is critical, particularly when studying STE5 dimerization:

  • Standard RIPA or NP-40 based buffers work for most applications

  • For studying metal-dependent interactions (such as those involving the Lim-like zinc finger domain), avoid chelating agents like EDTA or EGTA which can disrupt STE5 dimers

  • Include protease and phosphatase inhibitors to prevent protein degradation and modification

• Cross-linking Considerations: For detecting transient or weak interactions:

  • Consider mild cross-linking with formaldehyde (0.1-0.5%) prior to cell lysis

  • Optimize cross-linking time to preserve interactions without creating excessive background

• Washing Conditions: Balance between removing non-specific interactions and preserving specific ones:

  • For stable interactions: standard stringent washes with lysis buffer

  • For weak interactions: reduce detergent concentration or salt concentration in wash buffers

• Elution Strategy: Depending on downstream applications:

  • Harsh elution with SDS-PAGE sample buffer for maximum recovery

  • Mild elution with peptide competition for maintaining protein activity

• Controls: Essential controls include:

  • Non-specific antibody of the same isotype

  • Lysate from cells not expressing STE5 or expressing a non-relevant protein

  • Input sample (typically 5-10% of the amount used for IP)

Following these optimization strategies will help ensure specific and reproducible immunoprecipitation results when working with STE5 antibodies.

What are the critical considerations when using STE5 antibodies for detecting protein-protein interactions?

Detecting STE5 protein-protein interactions requires careful experimental design and consideration of several technical factors:

• Specificity Validation: Before conducting interaction studies, validate the specificity of your STE5 antibody:

  • Confirm recognition of both wild-type and mutant forms of STE5

  • Verify antibody specificity using STE5 deletion strains as negative controls

  • Determine cross-reactivity with related scaffold proteins

• Detection of Transient Interactions: STE5 interactions may be transient and difficult to capture:

  • Consider using in vivo crosslinking approaches

  • Implement sensitive detection methods (enhanced chemiluminescence)

  • Use genetic systems like two-hybrid assays as complementary approaches

• Buffer Composition Effects:

  • Metal chelators can disrupt STE5 dimers formed through the Lim-like zinc finger domain

  • Test multiple buffer conditions, particularly when investigating novel interactions

  • Include appropriate controls for buffer effects on protein stability

• Experimental Design for Co-IP Studies:

  • Express differently tagged versions of interaction partners (e.g., Myc-tagged STE5 and GST-STE5)

  • Immunoprecipitate with one tag-specific antibody (e.g., anti-Myc)

  • Detect co-precipitated proteins using antibodies against the second tag

• Quantitative Considerations:

  • Use appropriate loading controls for western blots

  • Consider densitometric analysis to quantify interaction strengths

  • Compare interaction efficiencies under different conditions (e.g., stimulated vs. unstimulated cells)

When reporting STE5 interaction data, researchers should include detailed methodological information about antibody dilutions, incubation conditions, and detection methods to ensure reproducibility.

How can I troubleshoot non-specific binding when using STE5 antibodies?

Non-specific binding is a common challenge when working with antibodies, including those against STE5. Several methodological approaches can help minimize this issue:

• Optimization of Blocking Conditions:

  • Test different blocking agents: 3-5% BSA, 3-5% milk, or commercial blocking buffers

  • Standard blocking protocols use 3% milk in TBST for 1 hour at room temperature

  • Extend blocking time for high-background applications

• Antibody Dilution Optimization:

  • Titrate antibody concentrations to find optimal signal-to-noise ratio

  • For western blotting, start with manufacturer-recommended dilutions (typically 1:1000)

  • For co-immunoprecipitation, verify antibody specificity before interaction studies

• Washing Protocol Refinement:

  • Increase number of washes (5-6 washes for high-background samples)

  • Use washing buffers with appropriate detergent concentration

  • Consider adding low concentrations of salt to reduce ionic interactions

• Sample Preparation Considerations:

  • Pre-clear lysates with protein A/G beads before immunoprecipitation

  • Use freshly prepared samples to minimize degradation products

  • Ensure complete cell lysis to release all target proteins

• Controls to Identify Non-specific Signals:

  • Include lysates from STE5 deletion strains

  • Use isotype control antibodies

  • Perform peptide competition assays with the immunizing peptide

• Cross-reactivity Management:

  • Pre-absorb antibodies with lysates from cells lacking STE5

  • Use highly purified antibody preparations

  • Consider monoclonal antibodies for applications requiring highest specificity

By systematically implementing these troubleshooting strategies, researchers can significantly improve the specificity and reliability of their results when using STE5 antibodies.

How can STE5 antibodies be used to investigate MAPK pathway dynamics?

STE5 antibodies are valuable tools for investigating the dynamics of MAPK pathway activation and regulation:

• Temporal Analysis of Pathway Activation:

  • Use anti-STE5 antibodies to immunoprecipitate STE5 complexes at different time points after pathway stimulation

  • Analyze co-precipitated proteins to determine the temporal order of complex assembly

  • Compare with phospho-specific antibodies (like anti-phospho-p44/42 MAPK) to correlate complex formation with downstream activation

• Spatial Organization Analysis:

  • Combine STE5 antibodies with subcellular fractionation to determine localization changes upon stimulation

  • Use immunofluorescence to visualize STE5 translocation in response to signals

  • Analyze membrane vs. cytoplasmic fractions for STE5 redistribution

• Quantitative Pathway Analysis:

  • Use western blotting with STE5 antibodies to determine scaffold abundance effects on signal propagation

  • Implement quantitative immunoblotting approaches using appropriate loading controls (e.g., Cdc28)

  • Correlate STE5 levels with pathway output measured by substrate phosphorylation

• Pathway Crosstalk Investigation:

  • Immunoprecipitate STE5 complexes and analyze for components of other signaling pathways

  • Compare STE5-associated complexes under different stimulation conditions

  • Use phospho-specific antibodies to analyze activation status of pathway components

Experimental evidence suggests that modulation of STE5 expression levels has quantitative effects on ultimate biological responses . When designing experiments to investigate pathway dynamics, researchers should consider both the abundance and activation state of STE5 and its binding partners.

What methodological approaches can distinguish between monomeric and dimeric forms of STE5?

Distinguishing between monomeric and dimeric forms of STE5 requires specialized experimental approaches:

• Native PAGE Analysis:

  • Use non-denaturing gel conditions to preserve protein-protein interactions

  • Compare migration patterns of wild-type STE5 with dimerization-defective mutants

  • Include positive controls with known dimerization properties

• Size Exclusion Chromatography:

  • Analyze STE5-containing complexes by gel filtration

  • Compare elution profiles under conditions that promote or inhibit dimerization

  • Combine with western blotting using STE5 antibodies to identify fractions containing the protein

• Genetic Complementation Approaches:

  • Utilize intragenic complementation between pairs of non-functional STE5 mutants

  • Test complementation in both ste5Δ and temperature-sensitive (ste5ts) strains

  • Correlate complementation with dimerization potential

• Co-immunoprecipitation of Differently Tagged Constructs:

  • Express two differently tagged forms of STE5 (e.g., Myc-tagged and GST-tagged)

  • Immunoprecipitate with antibodies against one tag (e.g., anti-Myc)

  • Detect co-precipitated protein using antibodies against the second tag

  • Test effects of dimer-disrupting conditions (e.g., EGTA or 1,10-phenanthroline)

• Biophysical Approaches:

  • Consider fluorescence resonance energy transfer (FRET) between tagged STE5 molecules

  • Implement bimolecular fluorescence complementation (BiFC) to visualize dimers in vivo

  • Use analytical ultracentrifugation to determine oligomeric state

When implementing these approaches, researchers should consider that STE5 dimerization may be transient and context-dependent, making it difficult to detect using methods that require stable interactions .

How do experimental conditions affect STE5 antibody performance in signaling studies?

The performance of STE5 antibodies in signaling studies can be significantly affected by experimental conditions:

• Buffer Composition Effects:

  • Metal chelators (EGTA, 1,10-phenanthroline) can disrupt STE5 dimers formed through zinc-binding domains

  • High salt concentrations may disrupt weak protein-protein interactions

  • Detergent selection can affect membrane-associated STE5 complexes

• Fixation and Permeabilization Considerations:

  • Similar to other signaling proteins, optimal fixation conditions vary by application

  • Paraformaldehyde fixation (4%) often preserves protein complexes while maintaining epitope accessibility

  • Buffer selection affects epitope accessibility, as seen with other signaling antibodies like phospho-STAT5

• Sample Preparation Timing:

  • Signal transduction events are often transient

  • Rapid sample processing is essential for capturing dynamic interactions

  • Consider time-course experiments to capture transient STE5-protein interactions

• Temperature Effects:

  • Some STE5 interactions may be temperature-sensitive

  • Temperature-conditional mutants (ste5ts) show different complementation patterns than complete deletions (ste5Δ)

  • Consider performing parallel experiments at different temperatures

• Protein Expression Level Effects:

  • STE5 abundance affects signal propagation quantitatively

  • Overexpression may create artificial interactions

  • Native expression levels provide more physiologically relevant results

When designing signaling studies using STE5 antibodies, researchers should carefully control these experimental variables and include appropriate controls to distinguish specific from non-specific effects.

What control experiments are essential when using STE5 antibodies?

When working with STE5 antibodies, several control experiments are essential to ensure result validity:

• Antibody Specificity Controls:

  • Negative control: Use lysates from STE5 deletion strains (ste5Δ) to confirm absence of signal

  • Peptide competition: Pre-incubate antibody with immunizing peptide to block specific binding

  • Isotype control: Use non-specific antibody of the same isotype to identify non-specific binding

• Expression Controls:

  • Input samples: Include analysis of input material (typically 5-10% of IP amount)

  • Loading controls: Use antibodies against stable reference proteins (e.g., Cdc28)

  • Expression verification: Confirm expression of STE5 mutants using specific antibodies

• Functional Controls:

  • Positive controls: Include wild-type STE5 samples

  • Negative controls: Include non-functional STE5 mutants

  • Activity verification: Correlate STE5 detection with functional readouts (e.g., MAPK phosphorylation)

• Technical Controls:

  • Multiple antibody dilutions to ensure operation in the linear range

  • Replicate experiments to ensure reproducibility

  • Multiple detection methods to confirm interactions (e.g., IP, two-hybrid, genetic complementation)

• System-specific Controls:

  • For yeast studies: Include both ste5Δ and temperature-sensitive (ste5ts) strains for comprehensive analysis

  • For mammalian studies: Include siRNA knockdown controls where applicable

Implementing these control experiments systematically will significantly enhance the reliability and interpretability of results obtained using STE5 antibodies.

What are the optimal conditions for western blotting with STE5 antibodies?

Optimizing western blotting conditions for STE5 antibodies requires attention to several technical parameters:

• Sample Preparation:

  • Lyse cells in appropriate buffer containing protease inhibitors

  • Denature samples in SDS-PAGE loading buffer at 95°C for 5 minutes

  • Load appropriate amount of protein (typically 20-50 μg total protein per lane)

• Gel Electrophoresis Considerations:

  • Use 8-10% polyacrylamide gels for optimal resolution of STE5 (similar to other large proteins like STAT5b at 90 kDa)

  • Include molecular weight markers to confirm expected size

  • Consider gradient gels for simultaneous analysis of STE5 and interaction partners of different sizes

• Transfer Parameters:

  • Transfer to nitrocellulose membranes (BioRad or equivalent)

  • Optimize transfer time and voltage for efficient transfer of large proteins

  • Verify transfer efficiency with reversible protein stains

• Blocking Conditions:

  • Block membranes in 3% milk in TBST solution for 1 hour at room temperature

  • Alternative blocking agents (5% BSA) may be required for phospho-specific applications

• Antibody Incubation:

  • Primary antibody incubation: Overnight at 4°C in blocking buffer

  • Typical dilutions: 1:1000 for most applications, up to 1:10000 for high-affinity antibodies

  • Secondary antibody: HRP-conjugated secondary antibodies at 1:10000 dilution

• Detection Optimization:

  • Use appropriate substrate sensitivity (SuperSignal West Pico or Femto) based on expected signal strength

  • Image acquisition: Use digital imaging systems (e.g., Versa-Doc 3000) for quantitative analysis

  • Optimize exposure times to avoid signal saturation

Following these optimized conditions will help ensure consistent and reliable western blotting results when using STE5 antibodies for research applications.

How do different fixation and permeabilization methods affect STE5 antibody performance?

Fixation and permeabilization methods significantly impact STE5 antibody performance in various applications:

• Fixation Method Effects:

  • Paraformaldehyde fixation (4%): Preserves protein structure while maintaining most epitopes

  • Methanol fixation: May expose some epitopes but can disrupt certain protein-protein interactions

  • Glutaraldehyde: Provides stronger fixation but may mask epitopes through excessive cross-linking

• Permeabilization Considerations:

  • Triton X-100 (0.1-0.5%): Standard for most applications

  • Saponin (0.1%): Gentler permeabilization for preserving membrane associations

  • Digitonin (0.01-0.1%): Selective permeabilization of plasma membrane

• Buffer Compatibility:

  • Different fixation buffers can affect epitope recognition

  • For other signaling proteins like STAT5, buffer selection dramatically affects antibody performance

  • Testing multiple buffer systems may be necessary for optimal results

• Application-specific Optimization:

  • For immunofluorescence: Milder fixation often preserves spatial information

  • For flow cytometry: Buffer selection critical for maintaining epitope accessibility

  • For immunoprecipitation: Native conditions may be required for certain applications

• Epitope Accessibility Considerations:

  • Some epitopes may be masked in native protein complexes

  • Fixation can expose or conceal different regions of STE5

  • Consider epitope location when selecting fixation methods

When implementing new applications with STE5 antibodies, researchers should systematically test different fixation and permeabilization methods to determine optimal conditions for their specific experimental system.

How should quantitative data from STE5 antibody experiments be analyzed?

Proper analysis of quantitative data from STE5 antibody experiments requires rigorous methodological approaches:

• Western Blot Quantification:

  • Use digital imaging systems for capturing non-saturated images

  • Perform densitometric analysis using appropriate software

  • Normalize STE5 signals to loading controls (e.g., Cdc28)

  • Calculate relative expression or activation using consistent reference points

• Statistical Analysis Considerations:

  • Perform experiments in biological triplicates at minimum

  • Use appropriate statistical tests based on data distribution

  • Report both p-values and effect sizes

  • Consider the functional significance of quantitative differences

• Time-course Data Analysis:

  • Plot temporal profiles of STE5 interactions or modifications

  • Compare kinetics between wild-type and mutant forms

  • Correlate STE5 dynamics with downstream signaling events (e.g., MAPK phosphorylation)

• Dose-Response Relationships:

  • Analyze how STE5 scaffold abundance affects signal propagation quantitatively

  • Determine whether relationships are linear or exhibit threshold effects

  • Compare dose-response profiles between different experimental conditions

• Interaction Strength Quantification:

  • For co-immunoprecipitation experiments, calculate interaction efficiency as the ratio of co-precipitated to input protein

  • Compare affinity between different interaction partners

  • Assess how mutations or conditions affect interaction strength

When reporting quantitative data from STE5 antibody experiments, researchers should include detailed methodological information about image acquisition parameters, analysis methods, and statistical approaches to ensure reproducibility.

How can STE5 antibody data be integrated with genetic and functional studies?

Integrating STE5 antibody data with genetic and functional studies provides comprehensive insights into protein function:

• Correlation of Protein Levels with Functional Outcomes:

  • Use STE5 antibodies to quantify protein expression in different genetic backgrounds

  • Correlate STE5 levels with phenotypic outcomes (e.g., mating efficiency)

  • Determine whether functional defects result from altered expression or activity

• Structure-Function Analysis Integration:

  • Use antibodies to verify expression of STE5 mutants with different functional properties

  • Correlate dimerization capacity with functional complementation

  • Map functional domains through combined antibody detection and mutational analysis

• Pathway Integration Approaches:

  • Compare STE5 complex formation with pathway activation markers

  • Analyze how genetic manipulations affect both STE5 interactions and signaling outputs

  • Use antibodies against pathway components to build comprehensive signaling models

• Multi-level Data Integration:

  • Combine protein-level data (from antibody studies) with:

    • Genetic data (from deletion and complementation studies)

    • Transcriptional data (from reporter gene assays)

    • Cellular phenotypes (from microscopy or flow cytometry)

• Computational Modeling Support:

  • Use quantitative antibody data to parameterize mathematical models

  • Test model predictions with targeted experiments

  • Refine models based on experimental feedback

The combination of STE5 antibody data with genetic and functional studies has been particularly powerful in establishing the biological significance of STE5 dimerization through multiple independent lines of evidence .

How are STE5 antibodies being used in emerging research techniques?

STE5 antibodies are finding applications in several emerging research techniques:

• Proximity Labeling Applications:

  • BioID or APEX2 fusion proteins combined with STE5 antibodies for validating interaction networks

  • Spatially restricted enzymatic tagging to identify context-specific STE5 interactors

  • Validation of proximity labeling results using conventional co-immunoprecipitation

• Super-resolution Microscopy:

  • Immunofluorescence with STE5 antibodies for nanoscale localization

  • Multi-color imaging to visualize STE5 scaffold complexes at the single-molecule level

  • Correlation of spatial organization with signaling efficiency

• Single-cell Analytical Approaches:

  • Flow cytometry with phospho-specific and STE5 antibodies for population heterogeneity analysis

  • Mass cytometry (CyTOF) integration for multi-parameter signaling analysis

  • Correlation of STE5 levels with pathway activation at the single-cell level

• Quantitative Interaction Proteomics:

  • SILAC or TMT labeling combined with STE5 immunoprecipitation

  • Identification of condition-specific interaction partners

  • Quantitative analysis of interaction dynamics under different stimulation conditions

• In situ Proximity Ligation Assays:

  • Direct visualization of STE5 protein interactions in fixed cells

  • Quantification of interaction frequencies in different cellular compartments

  • Validation of results from biochemical interaction studies

These emerging techniques, when combined with traditional STE5 antibody applications, provide powerful approaches for investigating scaffold protein function with unprecedented resolution and precision.

What are the challenges in developing and validating new STE5 antibodies?

Developing and validating new STE5 antibodies presents several significant challenges:

• Epitope Selection Considerations:

  • Identifying unique regions that distinguish STE5 from related scaffold proteins

  • Avoiding regions involved in protein-protein interactions that might be masked in complexes

  • Selecting epitopes that remain accessible after fixation and processing

• Validation Strategy Requirements:

  • Testing in multiple applications (western blot, IP, IF) for comprehensive characterization

  • Validation using genetic controls (STE5 deletion strains)

  • Confirming specificity across different experimental conditions

• Cross-species Reactivity Challenges:

  • Determining conservation of epitopes across model organisms

  • Validating antibody performance in each species individually

  • Documenting species limitations in antibody specifications

• Isoform and Modification Specificity:

  • Developing antibodies that distinguish between different STE5 isoforms if present

  • Creating modification-specific antibodies (e.g., phospho-STE5 antibodies)

  • Validating specificity using appropriate mutants or treatment conditions

• Reproducibility Concerns:

  • Ensuring lot-to-lot consistency in polyclonal antibody preparations

  • Establishing robust validation protocols for quality control

  • Documenting detailed antibody characteristics for research reproducibility

Addressing these challenges requires rigorous validation using multiple complementary approaches, including genetic controls, peptide competition, and cross-application testing. Researchers developing new STE5 antibodies should incorporate comprehensive validation strategies into their development pipeline.

How can STE5 antibodies contribute to translational research beyond basic science?

While STE5 research has traditionally focused on basic science in yeast model systems, STE5 antibodies can contribute to translational research in several ways:

• Comparative Pathway Analysis:

  • Investigating conservation of scaffold-mediated signaling mechanisms across species

  • Identifying functional equivalents of STE5 in mammalian systems

  • Using lessons from yeast STE5 to understand mammalian scaffold proteins

• Drug Discovery Applications:

  • Screening for compounds that modulate scaffold-mediated signaling

  • Using STE5 antibodies to validate target engagement in phenotypic screens

  • Developing assays for scaffold-targeting therapeutic approaches

• Synthetic Biology Platforms:

  • Engineering novel scaffold proteins based on STE5 design principles

  • Using STE5 antibodies to validate synthetic scaffold function

  • Developing tunable signaling systems for biotechnology applications

• Disease Mechanism Investigations:

  • Studying how scaffold protein dysregulation contributes to disease

  • Investigating parallels between yeast signaling and human pathway dysregulation

  • Using comparative approaches to identify conserved regulatory principles

• Methodological Advancements:

  • Developing improved antibody-based detection systems for quantitative signaling analysis

  • Creating new approaches for studying weak or transient protein interactions

  • Establishing standardized protocols for scaffold protein research

By leveraging the extensive knowledge gained from basic STE5 research, antibody-based approaches can contribute to broader understanding of signaling pathway organization and regulation with potential implications for human health and disease.